rotation.to
Following this device: dark.
Free account
rotation.to
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

The company

Organigram Global Inc. - Common Shares

OGI · Nasdaq

Health CareBiotechnologyNot moving yetCannabis

OGI stood above a rising 150-day average in 11 of the last 52 weekly readings, and has been out of that trend for the last 41 weeks. It is 17.1% below that average now. Biotechnology: 18% of its 561 stocks in an uptrend (−12 points in four weeks); Health Care: 28% (−6 points in four weeks).

Statistics

Rotation
Not moving yet
Weeks in an uptrend
out for 41
Industry in uptrend
18% -12 in 4 wk
Insider buys, 12 months
$0
Insider sales, 12 months
$0
Officials’ trades on record
0
Institutions holding
68 (-2)

In the rotation

Each square a week: lit when it closed above a rising 150-day average. 11 of 52 weeks.

22 Apr – 21 Oct
16%27%39%Apr 26Jun 26Jul 26Sep 26Oct 26

Biotechnology: Few of its stocks are in an uptrend and the share has fallen sharply over four weeks. Health Care: A minority of its stocks are in an uptrend and the share has been slipping.

Money in and out

1 Nov 2024 – 1 Oct 2026
−$1$0$1Nov 24May 25Nov 25Apr 26Oct 26

Open-market buys above the line and sales below, in dollars.

Congress and officials

No member of Congress or official has disclosed a trade in it.

Insiders

Buy orders, 12 months0
Sale orders, 12 months0
Buyers · sellers0 · 0

No open-market buy or sale by its insiders on record.

Lines filed since 2 January 2026, newest first; every insider’s older lines are on their own page.

Institutions

Holders68-2 on the quarter
New · exited10 · 13
Reported value$7.8M

Quarter to 30 Jun 2026, against 31 Mar 2026; newest filing 31 Aug 2026.

ManagerSharesChange
Tidal Investments LLCreduced · filed 13 Aug 20262,164,878$2.2M-3,519−0.2%
RENAISSANCE TECHNOLOGIES LLCreduced · filed 13 Aug 20261,444,148$1.5M-195,900−11.9%
AdvisorShares Investments LLCreduced · filed 11 Aug 2026888,057$906K-59,383−6.3%
GOLDMAN SACHS GROUP INCadded · filed 14 Aug 2026611,479$624K+40,110+7.0%
MORGAN STANLEYreduced · filed 13 Aug 2026308,108$314K-56,076−15.4%
Baader Bank Aktiengesellschaftreduced · filed 23 Jul 2026250,000$254K-12,980−4.9%
BANK OF MONTREALadded · filed 12 Aug 2026238,434$244K+380+0.2%
UBS Group AGadded · filed 13 Aug 2026208,770$213K+176,155+540.1%
DIMENSIONAL FUND ADVISORS LPreduced · filed 11 Aug 2026164,139$167K-9,745−5.6%
Formidable Asset Management, LLCadded · filed 17 Jul 2026160,311$215K+3,562+2.3%
31 Mar 2023 – 30 Jun 2026
44891Mar 23Mar 24Dec 24Sep 25Jun 26

Everyone who traded it

Nobody on record has traded it.

Same industry

MRNA ModernaLeading+168%
ENTX Entera BioLeading+53%
XNCR XencorLeading+41%

Distance from each stock’s own 150-day average.

Government contracts

No federal award is tied to it.

From its SEC filings

Share count trendFY 2021 · to 31 Aug 202191.3%

Analyst forecasts

No analyst forecasts yet.